<?xml version='1.0' encoding='utf-8'?>
<document id="29097225"><sentence text="Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study."><entity charOffset="30-40" id="DDI-PubMed.29097225.s1.e0" text="miconazole" /><entity charOffset="85-94" id="DDI-PubMed.29097225.s1.e1" text="Nestorone" /><entity charOffset="97-116" id="DDI-PubMed.29097225.s1.e2" text="segesterone acetate" /><entity charOffset="122-139" id="DDI-PubMed.29097225.s1.e3" text="ethinyl estradiol" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e0" e2="DDI-PubMed.29097225.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e0" e2="DDI-PubMed.29097225.s1.e1" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e0" e2="DDI-PubMed.29097225.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e0" e2="DDI-PubMed.29097225.s1.e3" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e1" e2="DDI-PubMed.29097225.s1.e1" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e1" e2="DDI-PubMed.29097225.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e1" e2="DDI-PubMed.29097225.s1.e3" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e2" e2="DDI-PubMed.29097225.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29097225.s1.e2" e2="DDI-PubMed.29097225.s1.e3" /></sentence><sentence text="To evaluate the effects of concurrent administration of three vaginal miconazole nitrate formulations on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol from a novel contraceptive vaginal ring (NES/EE CVR)"><entity charOffset="70-88" id="DDI-PubMed.29097225.s2.e0" text="miconazole nitrate" /><entity charOffset="136-145" id="DDI-PubMed.29097225.s2.e1" text="Nestorone" /><entity charOffset="148-167" id="DDI-PubMed.29097225.s2.e2" text="segesterone acetate" /><entity charOffset="173-190" id="DDI-PubMed.29097225.s2.e3" text="ethinyl estradiol" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e0" e2="DDI-PubMed.29097225.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e0" e2="DDI-PubMed.29097225.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e0" e2="DDI-PubMed.29097225.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e0" e2="DDI-PubMed.29097225.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e1" e2="DDI-PubMed.29097225.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e1" e2="DDI-PubMed.29097225.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e1" e2="DDI-PubMed.29097225.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e2" e2="DDI-PubMed.29097225.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29097225.s2.e2" e2="DDI-PubMed.29097225.s2.e3" /></sentence><sentence text="" /><sentence text="This was an open-label, randomized, crossover, drug-drug interaction study conducted over three menstrual cycles in healthy women with regular menses" /><sentence text=" We compared systemic exposure to NES and EE by determining area under the curve (AUC8-21d) with CVR only and CVR with each miconazole treatment"><entity charOffset="124-134" id="DDI-PubMed.29097225.s5.e0" text="miconazole" /></sentence><sentence text=" Three different miconazole formulations (single-dose suppository, multiple-dose suppository or multiple-dose cream) were administered in a single dose on day 8 or multiple doses on days 8-10 after CVR insertion"><entity charOffset="17-27" id="DDI-PubMed.29097225.s6.e0" text="miconazole" /></sentence><sentence text=" We evaluated safety and tolerability of the CVR in the presence of antimycotic comedication" /><sentence text="" /><sentence text="Forty-five participants were randomized, and 29 completed participation" /><sentence text=" Systemic exposure to NES and EE released from the CVR increased with single or multiple doses of miconazole suppositories but not with multiple-dose cream"><entity charOffset="98-108" id="DDI-PubMed.29097225.s10.e0" text="miconazole" /></sentence><sentence text=" The maximum EE geometric mean ratio (GMR) for AUC8-21d was 1" /><sentence text="67 (1" /><sentence text="51-1" /><sentence text="86) for single-dose and 1" /><sentence text="42 (1" /><sentence text="21-1" /><sentence text="66) for multiple-dose suppositories" /><sentence text=" By contrast, systemic exposure to NES and EE was comparable with and without miconazole cream (all GMRs and confidence intervals within 0"><entity charOffset="78-88" id="DDI-PubMed.29097225.s18.e0" text="miconazole" /></sentence><sentence text="80 to 1" /><sentence text="25)" /><sentence text=" Adverse events (AEs) were similar with CVR only and with all miconazole treatment groups"><entity charOffset="62-72" id="DDI-PubMed.29097225.s21.e0" text="miconazole" /></sentence><sentence text=" There were no serious treatment-related AEs" /><sentence text="" /><sentence text="Miconazole vaginal suppositories were associated with increased systemic levels of NES and EE, while systemic exposure with miconazole vaginal cream was comparable to no miconazole exposure"><entity charOffset="0-10" id="DDI-PubMed.29097225.s24.e0" text="Miconazole" /><entity charOffset="124-134" id="DDI-PubMed.29097225.s24.e1" text="miconazole" /><entity charOffset="170-180" id="DDI-PubMed.29097225.s24.e2" text="miconazole" /><pair ddi="false" e1="DDI-PubMed.29097225.s24.e0" e2="DDI-PubMed.29097225.s24.e0" /><pair ddi="false" e1="DDI-PubMed.29097225.s24.e0" e2="DDI-PubMed.29097225.s24.e1" /><pair ddi="false" e1="DDI-PubMed.29097225.s24.e0" e2="DDI-PubMed.29097225.s24.e2" /><pair ddi="false" e1="DDI-PubMed.29097225.s24.e1" e2="DDI-PubMed.29097225.s24.e1" /><pair ddi="false" e1="DDI-PubMed.29097225.s24.e1" e2="DDI-PubMed.29097225.s24.e2" /></sentence><sentence text="" /><sentence text="Coadministration of miconazole suppositories with the investigational NES/EE CVR led to higher systemic exposure of both hormones, while coadministration with miconazole cream did not affect hormone levels"><entity charOffset="20-30" id="DDI-PubMed.29097225.s26.e0" text="miconazole" /><entity charOffset="159-169" id="DDI-PubMed.29097225.s26.e1" text="miconazole" /><pair ddi="false" e1="DDI-PubMed.29097225.s26.e0" e2="DDI-PubMed.29097225.s26.e0" /><pair ddi="false" e1="DDI-PubMed.29097225.s26.e0" e2="DDI-PubMed.29097225.s26.e1" /></sentence><sentence text=" Women utilizing the NES/EE CVR may be advised to use an oral formulation or miconazole cream rather than suppository to treat vaginal candidiasis"><entity charOffset="77-87" id="DDI-PubMed.29097225.s27.e0" text="miconazole" /></sentence><sentence text="" /></document>